Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis

Overview of attention for article published in Patient preference and adherence, July 2017

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 749 followers.

Patients using the IFN beta-Ia autoinjector device highly adherent to treatment in daily #MS clinical practice https://t.co/90UvVneath

Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart(®) injection device: a retrospective… https://t.co/898XBrLvAR